Title 16

Volume 2 CHAPTER II SUBCHAP E

Subchapter E - Poison Prevention Packaging Act Of 1970 Regulations

16:2.0.1.5.117	PART 1700	PART 1700 - POISON PREVENTION PACKAGING
16:2.0.1.5.117.0.2.1	SECTION 1700.1	1700.1 Definitions.
16:2.0.1.5.117.0.2.2	SECTION 1700.2	1700.2 Authority.
16:2.0.1.5.117.0.2.3	SECTION 1700.3	1700.3 Establishment of standards for special packaging.
16:2.0.1.5.117.0.2.4	SECTION 1700.4	1700.4 Effective date of standards.
16:2.0.1.5.117.0.2.5	SECTION 1700.5	1700.5 Noncomplying package requirements.
16:2.0.1.5.117.0.2.6	SECTION 1700.14	1700.14 Substances requiring special packaging.
16:2.0.1.5.117.0.2.7	SECTION 1700.15	1700.15 Poison prevention packaging standards.
16:2.0.1.5.117.0.2.8	SECTION 1700.20	1700.20 Testing procedure for special packaging.
16:2.0.1.5.118	PART 1701	PART 1701 - STATEMENTS OF POLICY AND INTERPRETATION
16:2.0.1.5.118.0.2.1	SECTION 1701.1	1701.1 Special packaging for substances subject to a standard that are distributed to pharmacies to be dispensed pursuant to an order of a licensed medical practitioner.
16:2.0.1.5.118.0.2.2	SECTION 1701.3	1701.3 Applicability of special packaging requirements to hazardous substances in large size containers.
16:2.0.1.5.119	PART 1702	PART 1702 - PETITIONS FOR EXEMPTIONS FROM POISON PREVENTION PACKAGING ACT REQUIREMENTS; PETITION PROCEDURES AND REQUIREMENTS
16:2.0.1.5.119.0.2.1	SECTION 1702.1	1702.1 Purpose and policy.
16:2.0.1.5.119.0.2.2	SECTION 1702.2	1702.2 Procedural requirements and recommendations.
16:2.0.1.5.119.0.2.3	SECTION 1702.3	1702.3 Substantive requirements.
16:2.0.1.5.119.0.2.4	SECTION 1702.4	1702.4 Petitions with insufficient or incomplete information.
16:2.0.1.5.119.0.2.5	SECTION 1702.5	1702.5 Failure to supply adverse information.
16:2.0.1.5.119.0.2.6	SECTION 1702.6	1702.6 Trade secrets and other confidential information.
16:2.0.1.5.119.0.2.7	SECTION 1702.7	1702.7 Justification for the exemption.
16:2.0.1.5.119.0.2.8	SECTION 1702.8	1702.8 Human experience data.
16:2.0.1.5.119.0.2.9	SECTION 1702.9	1702.9 Relevant experimental data.
16:2.0.1.5.119.0.2.10	SECTION 1702.10	1702.10 Human experimental data involving the testing of human subjects.
16:2.0.1.5.119.0.2.11	SECTION 1702.11	1702.11 Product specifications.
16:2.0.1.5.119.0.2.12	SECTION 1702.12	1702.12 Packaging specifications.
16:2.0.1.5.119.0.2.13	SECTION 1702.13	1702.13 Labeling and packaging samples.
16:2.0.1.5.119.0.2.14	SECTION 1702.14	1702.14 Marketing history.
16:2.0.1.5.119.0.2.15	SECTION 1702.15	1702.15 Petitions alleging the incompatibility of child resistant packaging with the particular substance petitioned for exemption.
16:2.0.1.5.119.0.2.16	SECTION 1702.16	1702.16 Petitions requesting an exemption for a drug or a new drug.
16:2.0.1.5.119.0.2.17	SECTION 1702.17	1702.17 Granting petitions.
16:2.0.1.5.119.0.2.18	SECTION 1702.18	1702.18 Denying petitions.
16:2.0.1.5.119.0.2.19	SECTION 1702.19	1702.19 Effect of filing petition.

---